RE: Large Phase 2 trial of SNG001 happening. Will Jansen pay for it?26 Sep 2024 07:53
“At the same time, Synairgen has determined the financing plan, as previously announced, and intends to raise additional funds for the trial. ***Any fundraise will be structured, inter alia, to ensure existing investors are able to participate***, subject to demand…
…If this finance is not raised and the Phase 2 clinical trial does not commence, a fundraise will still be required by Q1 2026. Regardless of the outcome of these activities, which are uncertain, the Company's available resources are sufficient to cover existing committed costs to at least 31 December 2025…”
Very clearly dilution coming. By saying existing shareholders can participate, it means there has to be dilution and this isn’t a case of some BP being unusually generous and paying for it all.
Still a chance I suppose that regardless of a raise and dilution that they’ll be some kind of relief rally, given just what a mess we’ve got ourselves into.
And still astonished RM hasn’t fallen on his sword. Or that there has been no explanation for the dramatic change of plans and lack of money to implement said plans that were delivered last year.
Roll on the AGM.